Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.040

+0.010 (0.97%)

At close: Aug 13, 2025, 4:00 PM

1.060

+0.020 (1.92%)

After-hours: Aug 13, 2025, 7:00 PM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $227.48 million as of August 13, 2025. Its market cap has decreased by -63.44% in one year.

Market Cap

227.48M

Enterprise Value

33.60M

1-Year Change

-63.44%

Ranking

#3662

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $227.48M, a decrease of -92.10%. That is a compound annual growth rate of -30.99%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	227.48M	-49.06%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
Novartis AG	234.72B
AstraZeneca	232.33B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings